Treatments & Clinical Trials

Stay informed about the latest breakthroughs in stem cell therapies and clinical trials that hold promise for a wide range of medical conditions. Explore how groundbreaking treatments and ongoing research are paving the way for the future of healthcare.

Microfluidics for Birth Tissue Exosome Isolation

Microfluidic chips rapidly isolate high-purity exosomes from placenta and umbilical cord tissues, offering faster, gentler recovery than ultracentrifugation.

From Lab to Life: Stem Cell Trials Bringing Hope to Diabetics

Stem cell trials are restoring insulin production in some diabetes patients; cord-blood banking and immune-evasive cell strategies could expand access.

Can Stem Cells Replace Daily Insulin? Understanding Islet Transplants

Overview of stem cell-derived islet transplants, trial outcomes, immune-evasion strategies, costs, and timelines for replacing daily insulin in type 1 diabetes.

Islet Cell Transplants: How Regenerative Medicine is Tackling Diabetes

Islet cell transplants and stem‑cell therapies are shifting diabetes care from lifelong insulin to potential long-term insulin independence.

What is Wharton’s Jelly? The Hidden Power of Umbilical Cord Tissue

Explains Wharton's Jelly, its mesenchymal stem cells, medical uses, and benefits of cord tissue banking for future regenerative therapies.

Pediatric to Adult: The Growing Lifespan of Cord Blood Treatments

Stored cord blood stem cells remain viable for decades, treating 80+ conditions—from pediatric cancers to emerging adult regenerative therapies.

Blood Cancer Breakthroughs: How Expanded Cord Blood is Saving Lives

FDA-approved expanded cord blood therapies raise stem cell doses, speed neutrophil recovery, reduce infections, broaden donor access, and highlight the need to bank cord blood.